Advertisement
Screener

Echo Therapeutics, Inc. Increase (Decrease) in Accounts Receivable

Echo Therapeutics, Inc. Increase (Decrease) in Accounts Receivable

Echo Therapeutics, Inc. reported Increase (Decrease) in Accounts Receivable of $37.06 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2014-03-28.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2014-03-28

  • Echo Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2012-12-31 was $0.00, a 100.00% decline year-over-year.
  • Echo Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2012-09-30 was $3.55K.
  • Echo Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2012-06-30 was -$3.55K, a 105.06% decline year-over-year.
  • Echo Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2012-03-31 was $37.06K, a 8.17% increase year-over-year.
  • Echo Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2012 was $37.06K, a 64.50% decline from fiscal 2011.
  • Echo Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2011 was $104.42K.
  • Echo Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2010 was -$11.45K.
Period endIncrease (Decrease) in Accounts Receivable 3 monthIncrease (Decrease) in Accounts Receivable 6 monthIncrease (Decrease) in Accounts Receivable 9 monthIncrease (Decrease) in Accounts Receivable 12 month
2012-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28
$3.55K
derived: sum of 2 quarters · filed 2014-03-28
$0.00
derived: sum of 3 quarters · filed 2014-03-28
$37.06K
10-K · filed 2014-03-28
2012-09-30$3.55K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07
$0.00
derived: sum of 2 quarters · filed 2013-11-07
$37.06K
10-Q · filed 2013-11-07
$40.68K
derived: sum of 4 quarters · filed 2014-03-28
2012-06-30-$3.55K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
$33.51K
10-Q · filed 2013-08-09
$37.13K
derived: sum of 3 quarters · filed 2014-03-28
$33.51K
derived: sum of 4 quarters · filed 2014-03-28
2012-03-31$37.06K
10-Q · filed 2013-05-10
$40.68K
derived: sum of 2 quarters · filed 2014-03-28
$37.06K
derived: sum of 3 quarters · filed 2014-03-28
$107.22K
derived: sum of 4 quarters · filed 2014-03-28
2011-12-31$3.62K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28
$0.00
derived: sum of 2 quarters · filed 2014-03-28
$70.16K
derived: sum of 3 quarters · filed 2014-03-28
$104.42K
10-K · filed 2014-03-28
2011-09-30-$3.62K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08
$66.54K
derived: sum of 2 quarters · filed 2012-11-08
$100.80K
10-Q · filed 2012-11-08
-$28.39K
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30$70.16K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
$104.42K
10-Q · filed 2012-08-09
-$24.77K
derived: sum of 3 quarters · filed 2013-03-18
$27.55K
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31$34.27K
10-Q · filed 2012-05-10
-$94.93K
derived: sum of 2 quarters · filed 2013-03-18
-$42.61K
derived: sum of 3 quarters · filed 2013-03-18
2010-12-31-$129.19K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
-$76.87K
derived: sum of 2 quarters · filed 2013-03-18
-$11.45K
10-K · filed 2013-03-18
2010-09-30$52.32K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08
$117.74K
10-Q · filed 2011-11-08
2010-06-30$65.42K
10-Q · filed 2011-08-12